Lifecore Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 21, 2026	Dec '25 Dec 31, 2025	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022
Market Cap	176	307	249	172	241	291
Market Cap Growth	-36.56%	23.21%	44.86%	-28.66%	-17.35%	-17.04%
Enterprise Value	302.18	478.64	413.65	329.61	373.61	440.51
Last Close Price	4.69	8.18	6.72	5.62	7.94	9.87
PE Ratio	-	-	-	17.03	-	-
Forward PE	-	8.17	8.17	25.55	167.00	250.59
PEG Ratio	-	25.06	25.06	25.06	25.06	25.06
PS Ratio	1.36	-	1.93	1.34	2.33	2.62
PB Ratio	5.16	-21.59	186.24	15.18	-56.92	3.32
P/TBV Ratio	-	-	-	-	-	4.17
P/OCF Ratio	14.00	-	-	668.34	-	-
EV/Sales Ratio	2.33	-	3.21	2.57	3.62	3.96
EV/EBITDA Ratio	36.66	-	-	-	-	70.26
Debt / Equity Ratio	-5.20	-9.95	95.06	10.93	-26.19	0.54
Debt / EBITDA Ratio	52.37	-	-	-	-	23.96
Debt / FCF Ratio	23.26	-	-	-	-	-
Net Debt / Equity Ratio	-4.46	-8.72	88.87	10.19	-22.11	1.70
Net Debt / EBITDA Ratio	45.00	-	-12.88	-129.51	-10.85	23.80
Net Debt / FCF Ratio	19.99	-	-8.72	-6.35	-2.40	-2.84
Asset Turnover	0.55	0	0.52	0.51	0.39	0.29
Inventory Turnover	3.06	0	2.45	2.14	1.96	1.46
Quick Ratio	2.33	2.18	1.72	1.02	1.22	0.22
Current Ratio	3.79	3.49	2.84	2.08	2.39	0.66
Return on Equity (ROE)	142.58%	0.00%	-612.08%	263.40%	-153.69%	-10.65%
Return on Assets (ROA)	0.22%	0.00%	-6.98%	-3.55%	-8.21%	-3.80%
Return on Invested Capital (ROIC)	0.24%	0.00%	-13.97%	-5.29%	-9.61%	-4.51%
Return on Capital Employed (ROCE)	0.25%	0.00%	-8.13%	-4.12%	-13.95%	-4.72%
Earnings Yield	-	0.00%	-	5.87%	-	-
FCF Yield	3.54%	0.00%	-	-	-	-
Buyback Yield / Dilution	-1.63%	-7.64%	5.02%	-22.37%	-1.67%	-0.59%
Total Shareholder Return	-1.63%	-7.64%	5.02%	-22.37%	-1.67%	-0.59%

SEC Filings: 10-K · 10-Q